Опыт применения метформина у больных с синдромом поликистозных яичников и инсулинорезистентностью
Опыт применения метформина у больных с синдромом поликистозных яичников и инсулинорезистентностью
Карпова Е.А., Шереметьева Е.А., Андреева Е.Н. Опыт применения метформина у больных с синдромом поликистозных яичников и инсулинорезистентностью. Consilium Medicum. 2009; 11 (12): 95–98.
Опыт применения метформина у больных с синдромом поликистозных яичников и инсулинорезистентностью
Карпова Е.А., Шереметьева Е.А., Андреева Е.Н. Опыт применения метформина у больных с синдромом поликистозных яичников и инсулинорезистентностью. Consilium Medicum. 2009; 11 (12): 95–98.
Курмачева Н.А., Саяпин С.В., Киреев Р.Ф. и др. Опыт применения метформина у женщин с абдоминальным ожирением и бесплодием. Пробл. репрод. 2003; 9 (2): 51–4.
Мамедов М.Н., Метельская В.В., Перова Н.В. Метаболический синдром: пути реализации атеротромбогенного потенциала. Кардиология. 2000; 2: 83–9.
Шостак Н.А., Аничков Д.А. К вопросу о диагностических критериях метаболического синдрома. РМЖ. 2002; 10 (27): 1255–7.
Acbay O, Gundogdu S. Can metformin reduce insulin resistance in polycystic ovary syndrome? Fertil Steril 1996; 65: 946–9.
Andersen P et al. Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome. Metabolism 1995; 44: 611–7.
Argaud D, Roth H, Wiemsperger N et al. Metformin decreases gluconeogenesis by enhancing the pyruvate kinase flux in isolated rat hepatocytes. Eur J Biochem 1993; 213: 1341–8.
Barbieri R.L., Hornstein M.D. Hyperinsulinemia and ovarian hyperandrogenism: cause and effect. Endocrinol Metab Clin North Am 1988; 17: 685–97.
Barbieri R.L., Makris A, Ryan K.J. Insulin stimulates androgen accumulation in incubation of human ovarian stroma and theca. Obstet Gynecol 1984; 64: 73–80.
Caro F. Insulin resistance in obese and nonobese man. Clin Endocrinol Metab 1991; 73: 691–5.
Col V. New insights into insulin resistance pathophysiology: how it affects glucose and lipid metabolism. Rev Assoc Belge technol lab 2002; 29 (1): 9–19.
Diamanti-Kandarakis E, Kouli C, Tsianateli T, Bergiele A. Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome. Eur J Endocrinol 1998; 138: 269–74.
Dunaif A, Finegood D.T. b - Cell dysfunction independent of obesity and glucose intolerance in polycystic ovary syndrome. J Clin Endocrinol Metab 1996; 81: 942–7.
Ehrmann D.A., Cavaghan M.K., Imperial J et al. Effects of metformin on insulin secretion in polycystic ovary syndrome. J Clin Endocrinol 1995; 72: 489–512.
Ehrmann D.A., Barnes R.B., Rosenfield R.L. Polycystic ovary syndrome as form functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocrine Reviews 1995; 16: 322–53.
Ehrmann D.A., Cavaghan M.K., Imperial J et al. Effects of metformin on insulin secretion in polycystic ovary syndrome. J Clin Endocrinol 1995; 72: 489–512.
Fischer Y, Thomas J, Rosen P, Kammermeier H. Action of Metformin on Glucose - Transport and Glucose - Transporter Glut 1 Glut 4 in Heart-Muscle Cells from Hearlthy and Diabetic Rats. Endocrinology 1995; 136 (2): 412–20.
Gdansky E, Diamant Y.Z., Silbergeld A et al. Clin Endocrinol 1997; 47 (2): 185–90.
Klinger B, Anin S, Sibergeld A et al. Development of hyperandrogenism during treatment with insulin - like growth factor-1 (IGF-1) in female patients with Laron syndrome. Clin Endocrinol 1998; 48 (1): 81–7.
Landin K, Tengborn L, Smith U. Metformin and metoprolol CR treatment in nonobese men. J Intern Med 1994; 235: 335–41.
Marterns J.W.M., Geller D.H., Arlt W et al. Enzymatic Activities of P - 450c17 Stably Expressed in Fibroblasts from Patients with the Polycystic Ovary Syndrome. J Clin Endocrinol Metab 2000; 85 (11): 4338–52.
Trolle B, Flyvbjerg A, Kesmodel U, Lauszus F.F. Efficacy of metformin in obese and non - obese women with polycystic ovary syndrome: a randomized, double - blinded, placebo - controlled cross - over trial. Hum Reprod 2007; 22 (11): 2967–73.
Palomba S, Falbo A, Russo T et al. Insulin sensitivity after metformin suspension in normal - weight women with polycystic ovary syndrome. J Clin Endocrinol Metab 2007; 92 (8): 3128–35.